NCT06491953View on ClinicalTrials.gov

SGLT2-inhibitors on PC-AKI

Active, not recruitingOBSERVATIONAL
Enrollment

3,600

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 28, 2026

Conditions
Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy
Interventions
DRUG

SGLT-2 inhibitors

SGLT-2 inhibitors use or not use； the duration of SGLT-2 inhibitors use

Trial Locations (1)

Unknown

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER

NCT06491953 - SGLT2-inhibitors on PC-AKI | Biotech Hunter | Biotech Hunter